Skip to main content
. 2019 Sep 17;3:PO.19.00067. doi: 10.1200/PO.19.00067

FIG 1.

FIG 1.

Comparison of the rate of progression from metastatic hormone-sensitive prostate cancer (mHSPC) to metastatic castrate-resistant prostate cancer (mCRPC) between mutation carriers and noncarriers. (A) Rate of mHSPC to mCRPC progression conditioned on mutation status for the entire cohort. (B) Rate of mHSPC to mCRPC progression conditioned on mutation status for the mHSPC cohort. (C) Rate of mHSPC to mCRPC progression conditioned on mutation status for the mCRPC cohort.